Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

13/02/2023 06:00

Feb 13 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              176.26              144.02           236.00    
                   (+22.4 pct)                          (+18.2 pct) 
  Operating           28.60               23.35            33.00    
                   (+22.5 pct)                          (+13.7 pct) 
  Recurring           29.54               23.54            33.00    
                   (+25.5 pct)                          (+14.8 pct) 
  Net                 21.64               17.11            24.00    
                   (+26.5 pct)                          (+13.6 pct) 
  EPS               94.84 yen           75.00 yen       105.20 yen  
  EPS Diluted       94.57 yen           74.78 yen                   
  Ann Div                               36.00 yen        32.00 yen  
  -Q2 div           20.00 yen           15.00 yen                   
  -Q4 div                               21.00 yen        12.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T